Today: 8 February 2026
Subscribe
Browse Category

SGX:SEATR News 29 January 2026

Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus

Seatrium share price slips on SGX as Feb 26 results loom, DolWin 5 arbitration in focus

Seatrium shares slipped 0.5% to S$2.11 in Thursday afternoon trading, ahead of its Feb. 26 full-year results. The company remains locked in arbitration with Aibel over the DolWin 5 project, with claims totaling nearly 300 million euros. Both parties say any valid claims should be covered by existing consortium funds. The arbitration’s financial impact remains uncertain.
29 January 2026
·

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop